Researchers are developing a biomimetic intelligent nanoplatform for tumor synergy therapy, which may utilize cascade amplification effects. The platform could involve membrane-modified mesoporous silica nanoparticles or nanoprodrugs that are sensitive to certain conditions, such as hypoxia. The goal of this therapy appears to be enhancing anti-tumor strategies, potentially through the use of ultrasound triggers or immunomodulatory regulation.